Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)
Julie Wang(Shanghai Jiao Tong University), Charlotte Cunningham‐Rundles
Cited by 200
Related Papers
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|676
X-Linked Agammaglobulinemia
|Medicine|2006|637
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|504